ArticleJournal of translational medicine2014

Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells.

Jiandong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.